Sunshine Biopharma (SBFM) said on Thursday that it undertook a 1-for-20 reverse split of its common stock to regain compliance with Nasdaq’s minimum bid price requirement for continued listing. – Shares of the company dropped more than 21% in pre-market trading. – The reverse…
ock split will be effective on October 26, 2026. – The split will reduce the company’s issued and outstanding shares of common stock from 15,219,383 to about 760,969